Found: 10
Select item for more details and to access through your institution.
Personalized tumor vaccine for pancreatic cancer.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 301, doi. 10.1007/s00262-022-03237-x
- By:
- Publication type:
- Article
Combining a CAR and a chimeric costimulatory receptor enhances T cell sensitivity to low antigen density and promotes persistence.
- Published in:
- Science Translational Medicine, 2021, v. 13, n. 623, p. 1, doi. 10.1126/scitranslmed.abh1962
- By:
- Publication type:
- Article
Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine.
- Published in:
- British Journal of Haematology, 2019, v. 185, n. 4, p. 679, doi. 10.1111/bjh.15818
- By:
- Publication type:
- Article
MUC1‐C drives myeloid leukaemogenesis and resistance to treatment by a survivin‐mediated mechanism.
- Published in:
- Journal of Cellular & Molecular Medicine, 2018, v. 22, n. 8, p. 3887, doi. 10.1111/jcmm.13662
- By:
- Publication type:
- Article
A phase I study of lenalidomide plus chemotherapy with mitoxantrone, etoposide, and cytarabine for the reinduction of patients with acute myeloid leukemia.
- Published in:
- American Journal of Hematology, 2018, v. 93, n. 2, p. 254, doi. 10.1002/ajh.24968
- By:
- Publication type:
- Article
Bone marrow stroma protects myeloma cells from cytotoxic damage via induction of the oncoprotein MUC1.
- Published in:
- British Journal of Haematology, 2017, v. 176, n. 6, p. 929, doi. 10.1111/bjh.14493
- By:
- Publication type:
- Article
Individualized vaccination of AML patients in remission is associated with induction of antileukemia immunity and prolonged remissions.
- Published in:
- Science Translational Medicine, 2016, v. 8, n. 368, p. 1, doi. 10.1126/scitranslmed.aag1298
- By:
- Publication type:
- Article
Lenalidomide enhances anti-myeloma cellular immunity.
- Published in:
- Cancer Immunology, Immunotherapy, 2013, v. 62, n. 1, p. 39, doi. 10.1007/s00262-012-1308-3
- By:
- Publication type:
- Article
Rituximab-induced direct inhibition of T-cell activation.
- Published in:
- Cancer Immunology, Immunotherapy, 2012, v. 61, n. 8, p. 1233, doi. 10.1007/s00262-011-1168-2
- By:
- Publication type:
- Article
Allogeneic induced human FOXP3.
- Published in:
- European Journal of Immunology, 2009, v. 39, n. 10, p. 2703, doi. 10.1002/eji.200839097
- By:
- Publication type:
- Article